LCS
WGS icon

Levin Capital Strategies’s GeneDx Holdings WGS Stock Holding History

Levin Capital Strategies’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
+6,000
New +$341K 0.03% 191

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Levin Capital Strategies's WGS Position: Q2 2026 in Review

Levin Capital Strategies opened a new position in GeneDx Holdings (WGS) in Q2 2026: 6,000 shares worth $412K. The stake represents 0.03% of the portfolio and ranks #191 among its holdings.

223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Levin Capital Strategies held 6,000 shares of GeneDx Holdings worth $412K as of Q2 2026.
  • GeneDx Holdings was a new Levin Capital Strategies position in Q2 2026.
  • GeneDx Holdings made up 0.03% of Levin Capital Strategies's portfolio in Q2 2026, its #191 holding.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.